Abstract
The “pleiotropic” effects of statins have been the centre of a considerable research activity. Among the numerous experimental and clinical studies of this field, some focused on the effects of statins on blood pressure (BP), while others reported data on BP together with other parameters. Some of the animal or human studies do not show an association between statin treatment and BP changes, whereas others usually report mild but significant reductions. Among the latter, all clinical studies using ambulatory BP recordings show a significant drop in both systolic and diastolic BP in hypertensive patients. In addition, accumulating evidence has identified a number of statin actions that may be involved in BP lowering. Overall, current evidence suggests that statins can be associated with a mild beneficial effect on BP, but further research is needed to clarify the exact magnitude of this action, as well as its clinical relevance.
Keywords: Blood pressure, Statins, HMG-CoA reductase inhibitors, hypertension
Current Vascular Pharmacology
Title: Effects of Statins on Blood Pressure: A Review of the Experimental and Clinical Evidence.
Volume: 5 Issue: 2
Author(s): Pantelis A. Sarafidis, Angeliki I. Kanaki and Anastasios N. Lasaridis
Affiliation:
Keywords: Blood pressure, Statins, HMG-CoA reductase inhibitors, hypertension
Abstract: The “pleiotropic” effects of statins have been the centre of a considerable research activity. Among the numerous experimental and clinical studies of this field, some focused on the effects of statins on blood pressure (BP), while others reported data on BP together with other parameters. Some of the animal or human studies do not show an association between statin treatment and BP changes, whereas others usually report mild but significant reductions. Among the latter, all clinical studies using ambulatory BP recordings show a significant drop in both systolic and diastolic BP in hypertensive patients. In addition, accumulating evidence has identified a number of statin actions that may be involved in BP lowering. Overall, current evidence suggests that statins can be associated with a mild beneficial effect on BP, but further research is needed to clarify the exact magnitude of this action, as well as its clinical relevance.
Export Options
About this article
Cite this article as:
Sarafidis A. Pantelis, Kanaki I. Angeliki and Lasaridis N. Anastasios, Effects of Statins on Blood Pressure: A Review of the Experimental and Clinical Evidence., Current Vascular Pharmacology 2007; 5 (2) . https://dx.doi.org/10.2174/157016107780368307
DOI https://dx.doi.org/10.2174/157016107780368307 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardiovascular Manifestations of COVID-19
Current Cardiology Reviews Variation of Antioxidant Capacity in Different Layers of Onion (Allium cepa L.) At Two Different Stages of Maturation
Current Nutrition & Food Science Green Tea from the Far East to the Drug Store: Focus on the Beneficial Cardiovascular Effects
Current Pharmaceutical Design Drug Therapy Aimed at Adenylyl Cyclase to Regulate Cyclic Nucleotide Signaling
Endocrine, Metabolic & Immune Disorders - Drug Targets Sodium Intake, Circulating Microvesicles and Cardiovascular Outcomes in Type 2 Diabetes
Current Diabetes Reviews The Role of “Eye Platelet Rich Plasma” (E-Prp) for Wound Healing in Ophthalmology
Current Pharmaceutical Biotechnology The Role of PDE5-Inhibitors in Cardiopulmonary Disorders: From Basic Evidence to Clinical Development
Current Medicinal Chemistry Endogenous Events Modulating Myogenic Regulation of Cerebrovascular Function
Current Vascular Pharmacology Exercise Rehabilitation for the Patient with Intermittent Claudication: A highly Effective yet Underutilized Treatment
Current Drug Targets - Cardiovascular & Hematological Disorders Angiogenesis Inhibition in the Treatment of Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Soluble Amyloid-β Levels and Late-Life Depression
Current Pharmaceutical Design Overview of Murine Atherosclerosis Series
Current Drug Targets Synthesis and Biological Evaluation of a New Series of Benzothiazole-Benzothiadiazine Conjugates as Antibacterial Agents
Letters in Drug Design & Discovery Cadmium Removal from Aqueous Solution by Compound Bioflocculant: Equilibrium, Kinetics and Reuse Studies
Current Biotechnology Drug in Adhesive Transdermal Formulation of Valsartan and Nifedipine: Pharmacokinetics and Pharmacodynamics in Rats
Current Drug Therapy Diabetic Heart and the Cardiovascular Surgeon
Cardiovascular & Hematological Disorders-Drug Targets New Horizons in Diabetes Therapy: The Angiogenesis Paradox in Diabetes: Description of the Problem and Presentation of a Unifying Hypothesis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration
Current Drug Metabolism Premature Cardiovascular Disease in Women with Lupus and Relationship to Disease Severity
Current Women`s Health Reviews The Role of Prostaglandins in Liver Ischemia-Reperfusion Injury
Current Pharmaceutical Design